INOCLON

INOCLON, a flagship enterprise of Gooya Biotech Innovation Co., is the Middle East's pioneering industrial-scale producer of cell culture media and sterile pharmaceuticals. Founded in 2007, we supply globally recognized research institutions and pharmaceutical partners under our proprietary INOCLON® brand. Our GMP/ISO-certified manufacturing facilities deliver precision engineered solutions including cell culture media, ophthalmic drops, nasal sprays, nutraceuticals and cosmetics. Guided by our mission, "Your Health, Our Innovative Approach", we integrate cutting-edge biotechnology with uncompromising quality control to address critical healthcare challenges. Today, INOCLON is expanding its portfolio of pharmaceutical innovations while advancing regional self-sufficiency in drug production. We remain committed to sustainable practices, strategic R&D partnerships, and a vision of making high-impact therapeutics accessible worldwide.